mdlinx mdlinx
Oncology Articles on MDLinx
Latest (59) Full Text Top Read since last login Focus on Lung Article Summary

Postoperative long-term evaluation of interposition reconstruction compared with Roux-en-Y after total gastrectomy in gastric cancer: prospective randomized controlled trial
The American Journal of Surgery, 09/02/2011

Ishigami S et al. – Although authors' patient sample was small and patients who did not complete the follow–up survey were present, they could not identify any clinical difference between interposition of jejunum reconstruction (INT) and Roux–en–Y reconstruction (RY) after total gastrectomy 60 months after surgery. The safer and simpler RY method may be a more suitable reconstruction method than INT after total gastrectomy.

Methods
  • A total of 103 patients with gastric cancer were prospectively randomly divided into groups for RY (n = 51) or INT reconstruction (n = 52) after total gastrectomy.
  • They were stratified by sex, age, institute, histology, and degree of lymph node dissection.
  • Postoperatively, body mass index (BMI) and nutritional conditions were measured serially, and quality of life (QOL) and postoperative squalor scores were evaluated at 3, 12, and 60 months and compared between the 2 groups.

Results
  • After removing patients who did not complete the follow-up survey or censured cases, 24 patients in the RY group and 18 patients in the INT group were clinically available and their postoperative status was assessed.
  • QOL scores were increased and complication scores were improved in the postoperative periods (P < .01).
  • Postoperative BMI significantly deteriorated compared with preoperative BMI in each group.
  • The postoperative QOL and complication scores at 60 months after surgery were significantly better than those at 3 months after surgery in each group (P < .01).
  • However, there was no significant difference of QOL scores and postoperative complication scores between the 2 reconstruction groups.
  • The nutritional condition in the INT group was nearly the same as that in the RY group.

Read this article in The American Journal of Surgery read MDLinx article: Postoperative long-term evaluation of interposition reconstruction compared with Roux-en-Y after total gastrectomy in gastric cancer: prospective randomized controlled trial

<< Previous Article | Next Article >>
Showing Latest Articles
Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Oncology Articles

Last month's top read Top 50 of 2011

1 Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial The Lancet, May 22, 2012    Clinical Article

2 Continuous lenalidomide treatment for newly diagnosed multiple myeloma New England Journal of Medicine, May 15, 2012    Clinical Article

3 Sunitinib plus erlotinib versus placebo plus erlotinib in patients with previously treated advanced non-small-cell lung cancer: a phase III trial Journal of Clinical Oncology, May 9, 2012    Clinical Article

4 Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: final results of a phase III trial Journal of Clinical Oncology, May 3, 2012    Clinical Article

5 Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkins lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial The Lancet, May 15, 2012    Clinical Article

6 Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial The Lancet Oncology - Online First, May 10, 2012    Clinical Article

7 Comparative effectiveness of filgrastim, pegfilgrastim, and sargramostim as prophylaxis against hospitalization for neutropenic complications in patients with cancer receiving chemotherapy American Journal of Clinical Oncology, May 23, 2012

8 Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial The Lancet, May 22, 2012    Clinical Article

9 Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study Journal of Clinical Oncology, May 3, 2012    Clinical Article

10 Yoga for persistent fatigue in breast cancer survivors Cancer, May 2, 2012    Clinical Article

11 Dietary cadmium and risk of invasive postmenopausal breast cancer in the VITAL cohort Cancer Causes and Control, May 1, 2012    Clinical Article

12 Benefits and adverse events in younger versus older patients receiving adjuvant chemotherapy for colon cancer: Findings from The Adjuvant Colon Cancer Endpoints Data Set Journal of Clinical Oncology, May 29, 2012    Clinical Article

13 Lenalidomide after stem-cell transplantation for multiple myeloma New England Journal of Medicine, May 16, 2012    Clinical Article

14 Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301) The Lancet Oncology - Online First, May 24, 2012

15 Effect of (Neo)adjuvant zoledronic acid on disease-free and overall survival in clinical stage II/III breast cancer British Journal of Cancer, May 25, 2012

16 Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP Protocol B-24 Journal of Clinical Oncology, April 9, 2012    Clinical Article

17 Reliability of serum biomarkers of inflammation from repeated measures in healthy individuals Cancer Epidemiology, Biomarkers & Prevention, May 11, 2012

18 Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkins lymphoma Journal of Clinical Oncology, May 29, 2012    Clinical Article

19 Long-term neurotoxicity effects of oxaliplatin added to fluorouracil and leucovorin as adjuvant therapy for colon cancer: Results from National Surgical Adjuvant Breast and Bowel Project trials C-07 and LTS-01 Cancer, May 10, 2012    Clinical Article

20 The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal Full Text Journal of Gastrointestinal Oncology, April 16, 2012    Free full text    Clinical Article

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncologymore

Other Topics in Oncology

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Edit My Newsletter Settings

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close